文献速递乳房整形与再造美容整形

既往美容隆乳患者中的肿瘤整形重建

Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation.
PubMed 文献 · Plast Reconstr Surg · 2024-02-20

回顾性分析单中心2016年3月至2022年3月142例在保乳治疗时已有美容隆乳的患者,93例(65.5%)保留假体、49例(34.5%)取出假体;多因素logistic回归未将假体处理策略列为并发症或修整的独立预测因素,BREAST-Q BCT模块报告的患者报告结局在各假体处理组间无显著差异。

要点

  • 保乳治疗中保留乳房假体不增加并发症或修整风险。
  • 乳房假体位于胸肌下者更可能保留假体。
  • 肿瘤整形乳房固定术与更高并发症率相关,尤其在选择假体缩小的患者中。

核心结论

  • 保乳治疗期间保留乳房假体不增加并发症或修整风险,在隆乳女性中保乳治疗是安全方法且患者满意度高。

研究设计与样本

  • 单中心回顾性回顾2016年3月至2022年3月接受保乳治疗的142例患者,纳入乳腺癌诊断和保乳治疗时已有美容隆乳者,记录人口学、临床与治疗特征、假体细节、重建技术、并发症和修整,采用BREAST-Q BCT模块评估患者报告结局。

主要发现

  • 93例(65.5%)选择保留假体,49例(34.5%)在保乳治疗期间选择取出假体。
  • 乳房假体位于胸肌下的患者更可能保留假体。
  • 肿瘤整形乳房固定术与更高并发症率相关,尤其在选择假体缩小的患者中。
  • 多因素logistic回归未将假体处理策略确定为并发症或修整的独立预测因素。
  • 手术部位感染是假体取出的唯一预测因素,不同假体处理队列间患者报告结局无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study explored the surgical management and reconstruction options for augmented breasts in the context of breast conservation therapy (BCT) for breast cancer. The authors hypothesized that there would be no difference in the rates of complications, revisions, or patient satisfaction in patients who maintained their breast augmentation versus those who had their implants removed in the context of BCT. METHODS: The authors conducted a retrospective review of 142 patients who underwent BCT at a single center from March of 2016 to March of 2022. The study included patients who had a preexistent cosmetic augmentation at the time of breast cancer diagnosis and BCT. Patient demographics, clinical and treatment characteristics, breast implant details, reconstructive technique, complications, and revisions were recorded. Patient-reported outcomes were assessed using the BREAST-Q BCT module. RESULTS: Ninety-three patients (65.5%) chose to maintain their implants, whereas 49 (34.5%) elected to have them removed during BCT. Patients with submuscular implants were more likely to maintain their implants. Oncoplastic mastopexy was associated with higher complication rates, particularly in patients opting for implant downsizing. However, multivariate logistic regression did not identify implant management strategy as an independent predictor for complications or revisions. Surgical-site infection was the only predictor of implant explantation. Patient-reported outcomes did not differ significantly between the different implant management cohorts. CONCLUSIONS: This study demonstrates that maintaining breast implants during BCT does not increase the risk of complications or revisions. Overall, BCT in augmented women was found to be a safe approach, with high patient satisfaction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Camacho L, Chu CK, Mitchell MP, et al. Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation. Plast Reconstr Surg. 2024. PMID: 38376232. doi:10.1097/PRS.0000000000011366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。